Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Idec begins phase I/II trial for 9-AC

Nov. 19, 1997

Banyu describes protein farnesyltransferase inhibitors

Nov. 19, 1997

Kyowa Hakko's UCT-1072M1, a new antitumor antibiotic

Nov. 19, 1997

Sch-207278: new protein farnesyltransferase inhibitor of microbial origin

Nov. 19, 1997

Scripps prepares MCBI analogues of antitumor antibiotics

Nov. 19, 1997

SUNY discloses new taxoids

Nov. 18, 1997

Cardioprotective activity of monoHER demonstrated in preclinical models

Nov. 17, 1997

D-19575: new cytostatic drug without renal side effects

Nov. 17, 1997

Clinical results reported for Onco TCS

Nov. 17, 1997

VEGF inhibitors discovered by Zeneca

Nov. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...